- Home
- TEM
TEM
TEMPUS AI INC
as 01-17-2025 4:00pm EST
Stocks
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | 5.5B | IPO Year: | 2024 |
| Target Price: | $57.20 | AVG Volume (30 days): | 3.9M |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -8.52 | EPS Growth: | N/A |
| 52 Week Low/High: | $22.89 - $79.49 | Next Earning Date: | 02-17-2025 |
| Revenue: | $640,442,000 | Revenue Growth: | 32.13% |
| Revenue Growth (this year): | 32.7% | Revenue Growth (next year): | 38.77% |
Stock Insider Trading Activity of TEMPUS AI INC (TEM)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Fukushima Ryan | TEM | Chief Operating Officer | Jan 7 '25 | Sell | $40.24 | 20,000 | $792,191.52 | 983,842 | |
| Fukushima Ryan | TEM | Chief Operating Officer | Jan 2 '25 | Sell | $34.66 | 1,265 | $43,844.90 | 983,842 | |
| LEFKOFSKY ERIC P | TEM | CEO and Chairman | Dec 18 '24 | Sell | $38.33 | 187,655 | $7,045,334.02 | 9,561,752 | |
| Fukushima Ryan | TEM | Chief Operating Officer | Dec 16 '24 | Sell | $40.23 | 3,500 | $140,805.00 | 983,842 | |
| Rogers James William | TEM | Chief Financial Officer | Dec 16 '24 | Sell | $40.23 | 1,468 | $59,057.64 | 229,812 | |
| Phelps Erik | TEM | EVP & Chief Admin & Legal Off | Dec 16 '24 | Sell | $40.23 | 2,396 | $96,391.08 | 220,596 | |
| Bartolucci Ryan M | TEM | Chief Accounting Officer | Dec 16 '24 | Sell | $40.23 | 339 | $13,637.97 | 71,007 | |
| Polovin Andrew | TEM | EVP and General Counsel | Dec 16 '24 | Sell | $40.23 | 1,130 | $45,459.90 | 244,955 | |
| KEYWELL BRADLEY A | TEM | 10% Owner | Dec 11 '24 | Sell | $42.83 | 395,800 | $16,997,810.29 | 16,430,233 | |
| Leonsis Theodore | TEM | Director | Dec 11 '24 | Sell | $41.17 | 400,000 | $16,494,839.63 | 3,494,097 |
Latest TEMPUS AI INC News
TEM Breaking Stock News: Dive into TEM Ticker-Specific Updates for Smart Investing
Insider Monkey
3 days ago
Why Tempus AI (TEM) Is Among Wednesday’s Top Gainers?
MT Newswires
4 days ago
Tempus AI Launches FDA-Approved Solid Tumor Profiling Test
Business Wire
4 days ago
Tempus Announces the National Launch of FDA-Approved xT CDx Test
Insider Monkey
4 days ago
Tempus AI (TEM) Launches AI-Powered Whole-Genome Sequencing Test to Transform Precision Medicine
Business Wire
5 days ago
Tempus One Introduces New GenAI Capabilities to Query Millions of Unstructured Documents for Research and Clinical Care
Zacks
5 days ago
TEM Stock Declines Following Preliminary Q4 Sales Miss
GuruFocus.com
5 days ago
Cathie Wood's ARK Snaps Up Tempus AI Shares Despite Revenue Miss and Market Sell-Off
Insider Monkey
5 days ago
Here’s Why Tempus AI, Inc (TEM) Is Among Monday’s Top Losers
Compare TEM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TEM TEMPUS AI INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.